The role of soluble thrombomodulin (sTM) in risk stratification of hemorrhagic fever with renal syndrome and prognostic assessment
PLOS Neglected Tropical Diseases · 2026
DOI: 10.1371/journal.pntd.0014132 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2026. Verfasst von Min Wei und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, The Second Affiliated Hospital of Air Force Medical University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Hemorrhagic Fever with Renal Syndrome, Thrombomodulin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Basic Research Program of Shaanxi Province, QinChuangYuan High-Level Innovation and Entrepreneurship Talent Project.
Abstract (Originalsprache)
Objective
The increase in vascular permeability and bleeding caused by systemic endothelial damage is the most basic pathological change of hemorrhagic fever with renal syndrome(HFRS) caused by Hantavirus, but there is a lack of early biomarkers to detect the severity and prognosis of HFRS. Soluble thrombomodulin (sTM) is a sensitive marker of endothelial damage. In this study we investigated the role of sTM in the evaluation of the severity and prognosis of HFRS patients.
Methods
A retrospective analysis was conducted on 51 patients with HFRS treated in the Infectious Diseases Department of the Second Affiliated Hospital of Air Force Medical University from January 2023 to January 2024. We compared the changes of sTM among patients with HFRS in different phases and subtypes, and analyzed the correlation between sTM and related laboratory diagnostic indicators. Additionally, we evaluated the differences of sTM and related laboratory diagnostic indicators between survivors and non-survivors, and assessed the predictive ability of sTM for the mortality risk of HFRS patients based on the ROC curve, and determined the cut-off value of sTM.
Results
In the HFRS phases, sTM increased during the febrile phase, reached its peak during the hypotensive phase, and decreased during the oliguria-dipuria phase. In the HFRS subtypes, there was no difference between the mild and moderate subtypes ( P > 0.05), while in the moderate, severe, and critical subtypes, it showed a “stepwise” increase ( P < 0.05), with the greatest jump being from “severe” to “critical” ( P < 0.0001). Linear regression analysis revealed a strong positive correlation between sTM and SOFA scores (R² = 0.6076, P < 0.0001). The level of sTM in the non-survivor group (62.25 (54.60, 81.98) TU/mL) was significantly higher than that in the survivor group (28.10 (21.40, 44.15) TU/mL). The ROC curve indicated that the AUC of sTM was 0.9317, which had a high predictive value for the mortality risk of HFRS patients and was second only to SOFA (0.9309), and the combined AUC could reach 0.9492. When the cut-off of sTM was 49.98 TU/mL, the sensitivity and specificity were 81.36% and 100%. In addition, the Kaplan-Meiers survival analysis showed that when sTM ≥ 49.8 TU/mL, the 28-day mortality rate of HFRS patients was higher ( P < 0.01). Conclusion sTM serves as a valuable biomarker for risk stratification and prognosis evaluation in HFRS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, The Second Affiliated Hospital of Air Force Medical University, Xi'an, Shaanxi, China.
- Department of Traditional Chinese Medicine, The First Affiliated Hospital of Air Force Medical University, Xi'an, Shaanxi, China.
ORCID-Profile: Chuantao Ye
Förderung
- National Natural Science Foundation of China
- Natural Science Basic Research Program of Shaanxi Province
- QinChuangYuan High-Level Innovation and Entrepreneurship Talent Project
- Key Technologies Research and Development Program
- Clinical Research Projects of Air Force Medical University
Zitieren
APA
Wei, M., Xiao, Z., Cao, J., Du, X., Li, M., Zhang, R., Yang, X., Wu, S., Fan, C., Zhang, J., Lian, J., & Ye, C. (2026). The role of soluble thrombomodulin (sTM) in risk stratification of hemorrhagic fever with renal syndrome and prognostic assessment. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0014132
Vancouver
Wei M, Xiao Z, Cao J, Du X, Li M, Zhang R, et al. The role of soluble thrombomodulin (sTM) in risk stratification of hemorrhagic fever with renal syndrome and prognostic assessment. PLOS Neglected Tropical Diseases. 2026. doi:10.1371/journal.pntd.0014132
BibTeX
@article{Wei2026,
author = {Wei, Min and Xiao, Zhuoran and Cao, Jiaojiao and Du, Xinyi and Li, Mengyuan and Zhang, Rongrong and Yang, Xiaofei and Wu, Shasha and Fan, Chao and Zhang, Jing and Lian, Jianqi and Ye, Chuantao},
title = {The role of soluble thrombomodulin (sTM) in risk stratification of hemorrhagic fever with renal syndrome and prognostic assessment},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
doi = {10.1371/journal.pntd.0014132}
}
EUVIMED